That was only matched by your "new highs coming" at 4200 >>> the day before the first decent to 3800 started. But "you're always right".
And how about your 9/15 rally. Hey, at least I admit I was dead wrong. But 12/31 isn't here yet. 4476>>. S&P
Earn Play -Ashland- Description Ashland Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions. The Personal Care & Household segment provides a range of nature-based, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. The Intermediates and Solvents segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. Ashland Inc. was founded in 1924 and is based in Wilmington, Delaware. Profitability Profit Margin 38.89% Operating Margin(ttm) 11.70% Balance Sheet Total Cash(mrq) 629M Total Cash Per Share(mrq) 11.62 Total Debt(mrq) 1.42B<------------ heavy debt > $110 would be a 5 year breakout! > Rolling paper uptrend Says $125! Ashland named short-term buy idea at Deutsche Bank 05:25 ASH Deutsche Bank analyst David Begleiter placed a "Catalyst Call: Buy" on shares of Ashland as a short-term investment idea. The analyst believes Ashland will report fiscal Q4 EBITDA at or the above the high-end of its guidance range and provide a positive Q1 outlook. The "strong results and outlook" should be driven by pricing more than offsetting higher raw material, freight and energy costs and a continuing mix shift to high margin, Begleiter tells investors in a research note. GBA BUY ALERT-> ASH-$ 95.25
GUMMY-> CEL-SCI Corporation (CVM) NYSE American - NYSE American Delayed Price. Currency in USD 3.1600-0.0700 (-2.17%) At close: October 14 04:00PM EDT 3.4700 +0.3100 (+9.8101%)<------------- Pre-Market: 8:55AM EDT
CEL-SCI’S Multikine Reduced 5-year Death Rate From 54% to 22% in Phase 3 Study Patients Who Were Early Tumor Responders Prior to Any Standard of Care Treatment Mon, October 17, 2022, 8:50 AM In this article: CVM -2.17% 5 patients had no tumor left following a 3-week treatment of CEL-SCI’s investigational drug Multikine Images clearly show tumors in the patients’ oral cavity prior to treatment with Multikine and the disappearance of these tumors before any subsequent standard-of-care treatment, confirmed at surgery There were also partial responses of greater than 30% tumor burden reduction resulting from the Multikine treatment prior to subsequent standard of care treatment VIENNA, Va., October 17, 2022--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) today announced the availability to the public of an oral presentation delivered by Dr. Philip Lavin of groundbreaking tumor response and increased overall survival in head and neck cancer. This presentation includes data presented at the European Society for Medical Oncology (ESMO) Annual Congress on September 10, 2022 in Paris, France. The ESMO poster presentation was titled "Early response to Neoadjuvant Leukocyte Interleukin Injection (LI) immunotherapy extends overall survival (OS) in locally advanced primary squamous cell carcinoma (SCC) of the head & neck (HN): the IT-MATTERS Study (Clinicaltrials.gov NCT01265849)." The summary of the most recent data presented from this Phase 3 clinical trial is that a 3-week administration of CEL-SCI’s investigational Multikine* (LI) treatment achieved groundbreaking tumor response and increased overall survival in treatment naïve locally advanced primary head and neck cancer patients who are scheduled to receive surgery and radiotherapy as their indicated treatment. The study had 45 early tumor responses, including 5 complete and 40 partial responses; all were early tumor responses in that they followed a three-week Multikine treatment, were observed at surgery and occurred before radiotherapy. Early tumor response to Multikine treatment was both prognostic and predictive of overall survival. The Multikine tumor response was differentiating in that it was observed within a week after completion of the fixed 3-week Multikine treatment. The degree of response had a significant impact on subsequent survival, which qualifies Multikine early tumor response as a surrogate marker.
Our Top Picks For summer Flip-Flops Best Overall: TKEES Leather Flip Flops at Net-a-Porter Jump to Review Best Budget: Old Navy Sugarcane-Blend Flip-Flops at Gap.com Jump to Review Best Splurge: The Row Ginza Sandal at Nordstrom Jump to Review Best Out of style: STONEY'S Jump to Review Best Colorful: Melissa Free Flip Flop at Nordstrom Jump to Review Most Comfortable: Teva Mush II Flip-Flops at Amazon
YETI is a Lilly White brand. That bothers me. Make YETI Great Again. Do Black people drink out of YETI mugs>? It's a great X-Mas gift... So the PR guys at YETI really had to dream up a way to get a one Black person into one of their ads... and they had to go all the way to the The Seychelles. Meet Cosmo